Biopharmaceutical Companies Commitment Will Dramatically Increase Information Available to Researchers, Patients and the Public

Phrma: 07.24.13

The biopharmaceutical industry is firmly committed to enhancing public health through responsible reporting and publication of clinical research and safety information. Today, PhRMA joins the European Federation of Pharmaceutical Industries and Associations (EFPIA) in strengthening our long-standing commitment by endorsing joint Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers.

The Principles reflect the biopharmaceutical sector’s strong support for responsible data sharing that recognizes the importance of protecting patient privacy, respects the integrity of national regulatory systems, and maintains incentives for continued investment in biopharmaceutical research. We firmly believe that continuing to augment the amount of information that is shared responsibly will expand research and scientific knowledge, foster a collaborative scientific discovery process, and support patient care – all with the ultimate goal of improving public health. Read more